Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Versteeg

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Translational Oncology|August 3, 2013
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor PrognosisKristoffer von Stedingk, Jan Koster, Marta Piqueras, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activityLaurel T Bate-Eya, Hinco J Gierman, Marli E Ebus, et al.
BMC Cancer|July 14, 2012
Identification of BIRC6 as a novel intervention target for neuroblastoma therapyFieke Lamers, Linda Schild, Jan Koster, et al.
International Journal of Cancer|December 5, 2009
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationDirk Geerts, Jan Koster, David Albert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2012
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplificationLinda J Valentijn, Jan Koster, Franciska Haneveld, et al.
Genome Research|August 14, 2003
The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genesRogier Versteeg, Barbera D C van Schaik, Marinus F van Batenburg, et al.
Endocrine-Related Cancer|August 24, 2011
Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastropheFieke Lamers, Ida van der Ploeg, Linda Schild, et al.
Omics : a Journal of Integrative Biology|March 27, 2009
The construction of genome-based transcriptional unitsSander R van Hooff, Jan Koster, Tim Hulsen, et al.
Molecular Cancer|July 14, 2010
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patientsPaolo Fardin, Annalisa Barla, Sofia Mosci, et al.
Molecular and Cellular Biology|April 11, 2007
The three-dimensional structure of human interphase chromosomes is related to the transcriptome mapSandra Goetze, Julio Mateos-Langerak, Hinco J Gierman, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Translational Oncology|August 3, 2013
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor PrognosisKristoffer von Stedingk, Jan Koster, Marta Piqueras, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activityLaurel T Bate-Eya, Hinco J Gierman, Marli E Ebus, et al.
BMC Cancer|July 14, 2012
Identification of BIRC6 as a novel intervention target for neuroblastoma therapyFieke Lamers, Linda Schild, Jan Koster, et al.
International Journal of Cancer|December 5, 2009
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationDirk Geerts, Jan Koster, David Albert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2012
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplificationLinda J Valentijn, Jan Koster, Franciska Haneveld, et al.
Genome Research|August 14, 2003
The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genesRogier Versteeg, Barbera D C van Schaik, Marinus F van Batenburg, et al.
Endocrine-Related Cancer|August 24, 2011
Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastropheFieke Lamers, Ida van der Ploeg, Linda Schild, et al.
Omics : a Journal of Integrative Biology|March 27, 2009
The construction of genome-based transcriptional unitsSander R van Hooff, Jan Koster, Tim Hulsen, et al.
Molecular Cancer|July 14, 2010
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patientsPaolo Fardin, Annalisa Barla, Sofia Mosci, et al.
Molecular and Cellular Biology|April 11, 2007
The three-dimensional structure of human interphase chromosomes is related to the transcriptome mapSandra Goetze, Julio Mateos-Langerak, Hinco J Gierman, et al.
Pageof 14